Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2019-02-01 2019-01-30
Drug Identification Number 02403587 02403587
Brand name APO-MOMETASONE APO-MOMETASONE
Common or Proper name MOMETASONE MOMETASONE
Company Name APOTEX INC APOTEX INC
Ingredients MOMETASONE FUROATE MOMETASONE FUROATE
Strength(s) 50MCG 50MCG
Dosage form(s) SPRAY, METERED DOSE SPRAY, METERED DOSE
Route of administration NASAL NASAL
Packaging size 140MS 140MS
ATC code R01AD R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-01-28 2019-01-28
Estimated end date 2019-01-31 2019-01-31
Actual end date 2019-01-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments